ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0121

Association of Low Bone Density with Need for Early Revision After Elective Joint Replacement for Osteoarthritis in Postmenopausal Women

Rashmi Dhital1, P. Daniel Nicholas2, Gregory Emkey3 and Anthony Donato2, 1Reading Hospital and Medical Center, West Reading, 2Reading Hospital and Medical Center, West Reading, PA, 3Reading Hospital and Medical Center, Reading, PA

Meeting: ACR Convergence 2020

Keywords: Arthroplasty, Osteoarthritis, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Osteoporosis & Metabolic Bone Disease Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Total joint replacement (TJR) is the standard surgical treatment for end-stage hip and knee osteoarthritis (OA). Patient optimization may limit the need for early revision surgeries. Low bone mineral density (BMD) may cause periprosthetic fractures, osteolysis and implant migrations which can affect postoperative outcomes, but the data is limited. There is also no standardized approach to assess bone health prior to TJR. Our primary objective was to study the prevalence of low bone mass and its relationship to early revision arthroplasty.

Methods: We performed a retrospective, case-control, single-center study using Reading Hospital Joint Database. We reviewed charts of postmenopausal women who underwent hip and knee arthroplasty from January, 2013 to December, 2019 and identified patients who underwent early (within 5 years) revision arthroplasty for aseptic indications (“cases”). We matched each of the cases to 2 postmenopausal women who did not undergo a revision surgery during the time period (“controls”), matched for age at index surgery (+/- 5 years), timing of initial TJR (+/- 6 months) and type of TJR. We identified patients with BMD testing with DEXA (dual-energy X-ray absorptiometry) within 2 years of the index TJR. We collected data on patient characteristics including age, body mass index (BMI), use of vitamin D and calcium, chronic glucocorticoid (prednisone equivalent of 5 mg/day for > 3 months) and anti-osteoporotic therapy use.  Late revision surgeries and infectious indications were excluded.

Results: We identified 25 postmenopausal women with elective TJR for OA who underwent early revision hip (n=11) and knee replacement (n=14) for aseptic indications.  The mean age for index TJR was 70 years. The average duration between index and revision surgery was 22 months (12 months for hip and 30 months for knee revision).

Each of the postmenopausal women who underwent early joint revision (n=25) were matched to 2 postmenopausal women who did not undergo early revision surgery (n=50) during the study period (Table 1). Forty percent patients in the early revision group had documentation of a screening DEXA compared to 60 % patients in the non-revision group. Among patients who had DEXA, 7/10 (70%) had low bone mass (osteopenia or osteoporosis) in the early revision group compared to 17/31 (55%) in the non-revision group. Of the 4 patients with a history of fragility fracture in the early revision group, 75% underwent revision surgery within the first 2 months of index TJR (two due to periprosthetic fracture and one due to femoral loosening). The use of calcium and vitamin D was identified in 40% and 52% in the early revision group compared to 44% and 68%, respectively, in the non-revision group.

Conclusion: Our study found a lower rate of DEXA screening and a higher prevalence of low bone mass in the early revision group, which may suggest a higher prosthetic failure in patients with low bone mass. We were unable to assess the role of anti-osteoporosis medication on the outcome due to the small sample size. Further studies are needed to explore the impact of osteoporosis and its treatment on postoperative outcomes, particularly in those with a history of a prior fragility fracture.

Table 1: Characteristics of postmenopausal women undergoing early joint revision (n=25) compared to those who did not undergo revision surgery during the study period (n=50) *Matched by age at index surgery (+/- 5 years), timing of initial TJR (+/- 6 months) and type of TJR


Disclosure: R. Dhital, None; P. Nicholas, None; G. Emkey, None; A. Donato, None.

To cite this abstract in AMA style:

Dhital R, Nicholas P, Emkey G, Donato A. Association of Low Bone Density with Need for Early Revision After Elective Joint Replacement for Osteoarthritis in Postmenopausal Women [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/association-of-low-bone-density-with-need-for-early-revision-after-elective-joint-replacement-for-osteoarthritis-in-postmenopausal-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-low-bone-density-with-need-for-early-revision-after-elective-joint-replacement-for-osteoarthritis-in-postmenopausal-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology